companydata.dkcompanydata.dk

ORIFARM GENERICS HOLDING A/S: Financial statements 2018

CVR: 27347223

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2018. In 2018, the company reported a gross profit of EUR 846,000 and a net result of EUR 5,504,000 compared with EUR 8,507,000 the year before. That is an increase of 20.7% compared with the year before. Equity in the 2018 report amounted to EUR 35,923,000. The solvency ratio was 53%. The company had 203 employees in the financial year.

Gross Profit
EUR 846,000
Profit/Loss
EUR 5,504,000
Equity
EUR 35,923,000
Total Assets
EUR 67,716,000
Employees
203

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-846K EUR5.5M EUR35.9M EUR203
2017-701K EUR8.5M EUR38.5M EUR188
2016-1M EUR9M EUR35M EUR165
2015-5.7M5.2M194.3M-
2014-8.2M4.1M15.3M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

ORIFARM GENERICS HOLDING A/S: The 2017 annual report is outMay 31, 2018

ORIFARM GENERICS HOLDING A/S has published its annual report for 2017. Gross profit came to DKK 701,000, and the net result was DKK 8,507,000.

Karsten Haumann joins ORIFARM GENERICS HOLDING A/S as adm. dir.May 15, 2018

As of May 15, 2018, Karsten Haumann is registered as adm. dir. of ORIFARM GENERICS HOLDING A/S.

Ulrik Ernst Rasmussen steps down as adm. dir. of ORIFARM GENERICS HOLDING A/SMay 15, 2018

As of May 15, 2018, Ulrik Ernst Rasmussen has stepped down as adm. dir. of ORIFARM GENERICS HOLDING A/S.

About ORIFARM GENERICS HOLDING A/S

ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.

Source: annual report 2025, Danish Business Authority